Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle E McClements

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
International Journal of Molecular Sciences|October 16, 2025
Gene Therapy Strategies for the Treatment of BestrophinopathiesSilja B Haldrup, Michelle E McClements, Jasmina Cehajic-Kapetanovic, et al.
Human Gene Therapy|May 13, 2020
Effect of AAV-Mediated Rhodopsin Gene Augmentation on Retinal Degeneration Caused by the Dominant P23H Rhodopsin Mutation in a Knock-In Murine ModelHarry O Orlans, Alun R Barnard, Maria I Patrício, et al.
International Journal of Molecular Sciences|January 30, 2020
RNA editing as a therapeutic approach for retinal gene therapy requiring long coding sequencesLewis E Fry, Caroline F Peddle, Alun R Barnard, et al.
JAMA Ophthalmology|September 24, 2020
Association of a Novel Intronic Variant in RPGR With Hypomorphic Phenotype of X-Linked Retinitis PigmentosaJasmina Cehajic-Kapetanovic, Michelle E McClements, Jennifer Whitfield, et al.
Biomed Research International|April 25, 2022
AAV Induced Expression of Human Rod and Cone Opsin in Bipolar Cells of a Mouse Model of Retinal DegenerationMichelle E McClements, Federica Staurenghi, Meike Visel, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 20, 2024
Rescue of cone and rod photoreceptor function in a CDHR1-model of age-related retinal degenerationImran H Yusuf, Thomas Burgoyne, Ahmed Salman, et al.
Expert Opinion on Orphan Drugs|May 27, 2021
Is subretinal AAV gene replacement still the only viable treatment option for choroideremia?Ruofan Connie Han, Lewis E Fry, Ariel Kantor, et al.
Progress in Retinal and Eye Research|August 10, 2024
Genetic therapies and potential therapeutic applications of CRISPR activators in the eyeBenjamin Wj Ng, Maria K Kaukonen, Michelle E McClements, et al.
International Journal of Molecular Sciences|July 18, 2020
Immunomodulatory Effects of Hydroxychloroquine and Chloroquine in Viral Infections and Their Potential Application in Retinal Gene TherapyLaurel C Chandler, Imran H Yusuf, Michelle E McClements, et al.
Human Gene Therapy|September 30, 2020
Genome-Editing Strategies for Treating Human Retinal DegenerationsJoel Quinn, Ayesha Musa, Ariel Kantor, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
International Journal of Molecular Sciences|October 16, 2025
Gene Therapy Strategies for the Treatment of BestrophinopathiesSilja B Haldrup, Michelle E McClements, Jasmina Cehajic-Kapetanovic, et al.
Human Gene Therapy|May 13, 2020
Effect of AAV-Mediated Rhodopsin Gene Augmentation on Retinal Degeneration Caused by the Dominant P23H Rhodopsin Mutation in a Knock-In Murine ModelHarry O Orlans, Alun R Barnard, Maria I Patrício, et al.
International Journal of Molecular Sciences|January 30, 2020
RNA editing as a therapeutic approach for retinal gene therapy requiring long coding sequencesLewis E Fry, Caroline F Peddle, Alun R Barnard, et al.
JAMA Ophthalmology|September 24, 2020
Association of a Novel Intronic Variant in RPGR With Hypomorphic Phenotype of X-Linked Retinitis PigmentosaJasmina Cehajic-Kapetanovic, Michelle E McClements, Jennifer Whitfield, et al.
Biomed Research International|April 25, 2022
AAV Induced Expression of Human Rod and Cone Opsin in Bipolar Cells of a Mouse Model of Retinal DegenerationMichelle E McClements, Federica Staurenghi, Meike Visel, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 20, 2024
Rescue of cone and rod photoreceptor function in a CDHR1-model of age-related retinal degenerationImran H Yusuf, Thomas Burgoyne, Ahmed Salman, et al.
Expert Opinion on Orphan Drugs|May 27, 2021
Is subretinal AAV gene replacement still the only viable treatment option for choroideremia?Ruofan Connie Han, Lewis E Fry, Ariel Kantor, et al.
Progress in Retinal and Eye Research|August 10, 2024
Genetic therapies and potential therapeutic applications of CRISPR activators in the eyeBenjamin Wj Ng, Maria K Kaukonen, Michelle E McClements, et al.
International Journal of Molecular Sciences|July 18, 2020
Immunomodulatory Effects of Hydroxychloroquine and Chloroquine in Viral Infections and Their Potential Application in Retinal Gene TherapyLaurel C Chandler, Imran H Yusuf, Michelle E McClements, et al.
Human Gene Therapy|September 30, 2020
Genome-Editing Strategies for Treating Human Retinal DegenerationsJoel Quinn, Ayesha Musa, Ariel Kantor, et al.
Pageof 7